Worldwide coverage of newborn screening for congenital hypothyroidism-a public health challenge

Stephen Lafranchi

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Despite the fact that programs began detecting neonates with congenital hypothyroidism (CH) over 40 years ago, at present only 30 % of the world birth population (approximately 127 million) undergoes screening for this disorder. The estimated cost of detection by screening, $15,400 compares with a lifetime expense of $1,296,000 in developed countries. The annual cost of the 30,000 CH cases not identified and treated early is approximately $40 billion dollars. Increasing the coverage of newborn screening worldwide remains a significant public health challenge.

Original languageEnglish (US)
Pages (from-to)115-116
Number of pages2
JournalUS Endocrinology
Volume10
Issue number2
DOIs
StatePublished - 2014

Keywords

  • Congenital hypothyroidism
  • Cost-benefit
  • Neonates
  • Newborn screening
  • Thyroid-stimulating hormone (TSH)
  • Thyroxine (T4)

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Worldwide coverage of newborn screening for congenital hypothyroidism-a public health challenge'. Together they form a unique fingerprint.

  • Cite this